ALPS Advisors’s Intersect ENT, Inc XENT Stock Holding History

ALPS Advisors’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-53,893	Closed	-$1.55M	–	974
2018 Q3	$1.55M	Buy	53,893 +10,160	+23%	+$305K	0.01%	286
2018 Q2	$1.64M	Buy	+43,733	New	+$1.72M	0.01%	251

Other funds holding XENT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

ALPS Advisors's XENT Position: Q4 2018 in Review

ALPS Advisors sold out of Intersect ENT, Inc (XENT) in Q4 2018, closing a stake of 53,893 shares — an estimated $1.55M sold.

ALPS Advisors first reported a position in XENT in Q2 2018 and held it in 2 quarters. The position peaked at $1.64M in Q2 2018. 136 funds tracked by Wall St. Rank hold XENT as of Q4 2018.

ALPS Advisors reported no remaining Intersect ENT, Inc position as of Q4 2018 after selling out during the quarter.
ALPS Advisors sold 53,893 Intersect ENT, Inc shares in Q4 2018, an estimated $1.55M.
ALPS Advisors first reported a position in Intersect ENT, Inc in Q2 2018 and held it in 2 quarters.
ALPS Advisors's Intersect ENT, Inc position peaked at $1.64M in Q2 2018.
136 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2018.

Based on ALPS Advisors's 13F filing for Q4 2018, filed 4 Feb 2019.